Home | Articles
Published on:March 2017
Indian Journal of Pharmaceutical Education and Research, 2017; 51(2):226-238
Original Article | doi:10.5530/ijper.51.2.28

Opportunities and challenges for Indian Pharmaceutical companies in overseas markets and need of digital tools for sustainable success


Authors and affiliation (s):

Arenur Venkataswamy Jayapala Reddy*1, Bandlamudi Madhusdhan Rao2

1Ph.D Research Scholar (International Business), School of Management Studies, Vignan’s University, Vadlamudi, Guntur District, Andhra Pradesh, INDIA/ Associate Vice President & Global Head - Biologics Business Development, Hetero Labs Ltd, Hyderabad – 500018, Telangana, INDIA.

2Professor, School of Management Studies, Vignan’s University, Vadlamudi, Guntur District, Andhra Pradesh, INDIA.

Abstract:

Background: The era of globalization has helped many Indian Pharma companies to expand operations beyond home turf. Changes in regulatory, patent and market trends will drive opportunities for generic drugs and hence very big opportunities for Indian pharmaceutical companies in global markets. India is the largest manufacturer and exporter of generic drugs in the world and considered as the pharmacy of the world. However many Indian pharma companies find it difficult to survive in global markets due to the competition, lack of market knowledge, complex regulatory pathway and not embracing the latest digital technologies adopted by global companies. Objective: The objective of this research is to study the need of various digital tools available for different domains of pharma industry to become successful in global markets. Methods: Researcher has adopted an empirical study to conduct this research using primary and secondary data. Primary research was done by identifying target participants from pharma industry and adopted purposive sampling technique to collect the data online through a structured and validated questionnaire. Data was extracted, analyzed and interpreted using graphical analysis. Results: The results of this study found that in all the questions in questionnaire, majority of the participants were in favor of adopting digital tools in pharma industry irrespective size and type organization. Conclusion: Based on the outcome of this empirical study, it was established that there is a clear need of domain based digital tools for Indian pharma companies to compete and sustain in global markets.

Key words: Indian pharma industry, Digital tools, Global markets, Globalization, Digital strategy, Automation in pharma, Pharma domain.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs